CORRESP Filing
Pasithea Therapeutics Corp.
Date: May 1, 2025 · CIK: 0001841330 · Accession: 0001213900-25-038338
AI Filing Summary & Sentiment
File numbers found in text: 333-286889
Show Raw Text
CORRESP
1
filename1.htm
May 1, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street NE
Washington, D.C. 20549
Re:
Pasithea Therapeutics Corp.
Registration Statement on Form S-1
File No. 333-286889
Ladies and Gentlemen:
In accordance with Rule 461
under the Securities Act of 1933, as amended (the "Securities Act"), H.C. Wainwright & Co., LLC. ("Wainwright"),
as placement agent on a best-efforts basis, hereby joins Pasithea Therapeutics Corp. in requesting that the Securities and Exchange Commission
take appropriate action to cause the Registration Statement on Form S-1 (File No. 333-286889) (the "Registration Statement")
to become effective on Monday, May 5, 2025, at 12:00 p.m., Eastern Time, or as soon as practicable thereafter. Wainwright affirms that
it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.
[Signature Page Follows]
Very truly yours,
H.C. WAINWRIGHT & CO., LLC.
By:
/s/ Edward
D. Silvera
Name:
Edward D. Silvera
Title:
Chief Operating Officer
[Signature Page to Acceleration Request]